Barclays starts coverage with USD 24.00 target for Bausch + Lomb stock

Published on 10/15/2026 at 21:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 28, 2026. Bausch + Lomb stock costs EUR 14.70 on October 15, 2026, while its NYSE quote is up 2.62 percent.

Analyst target and reporting date

On October 6, 2026, Barclays analyst Christopher Pasquale initiated coverage with an Overweight rating and a USD 24.00 target.
Bausch + Lomb will release third-quarter results on October 28, 2026.
Bausch + Lomb stock costs EUR 14.70 at Lang & Schwarz on October 15, 2026 at 8:59 p.m. CEST, while the NYSE quote was up 2.62 percent on the day.
Bausch + Lomb had a USD 5.9 billion market capitalization and a negative 34.42 price-to-earnings ratio on October 15, 2026.

BLCO, CA0717051076, Illustration mit AI erstellt.

Barclays analyst Christopher Pasquale initiated coverage of Bausch + Lomb with an Overweight rating and a USD 24.00 price target on October 6, 2026, according to Markets Insider. The target is 45.81 percent above the NYSE quote of USD 16.46. Bausch + Lomb stock was trading at EUR 14.70 at Lang & Schwarz on October 15, 2026 at 8:59 p.m. CEST, while the NYSE quote was up 2.62 percent on the day.

Barclays sets a 45.81 percent gap

The Barclays target gives investors a clearly defined valuation marker in the same home-exchange currency as the stock. The target distance is calculated against the USD 16.46 NYSE quote at 3:00 p.m. ET on October 15, 2026, when the exchange was open.

Results date is October 28

Bausch + Lomb is scheduled to release its third-quarter 2026 financial results on October 28, 2026, at 8:00 a.m. ET. The date and conference-call timing were announced in the company's release carried by Bausch + Lomb. That event is the next scheduled test of the growth assumptions behind the analyst target.

Price position on October 15

The USD 16.46 NYSE quote stood above the 52-week low of USD 14.44 and below the 52-week high of USD 18.92 on October 15, 2026. The spread between those endpoints puts the current home-market price 12.98 percent below the 52-week high and 14.00 percent above the low. Trading volume was 555,300 shares against an average of 441,787.

Valuation and comparison

Bausch + Lomb's market capitalization was USD 5.9 billion on October 15, 2026, while its trailing price-to-earnings ratio was negative 34.42. Its comparison with two eye-care peers shows a higher daily move but a weaker earnings multiple: the same-day NYSE quote for Alcon was up 4.12 percent, with a P/E of 51.16 and market capitalization of USD 32.1 billion; The Cooper Companies was up 4.24 percent, with a P/E of 19.53 and market capitalization of USD 10.9 billion.

Comparison with peers

Bausch + Lomb: plus 2.62 percent, P/E negative 34.42, market capitalization USD 5.9 billion.

Alcon (NYSE, USD): plus 4.12 percent, P/E 51.16, market capitalization USD 32.1 billion.

The Cooper Companies (NYSE, USD): plus 4.24 percent, P/E 19.53, market capitalization USD 10.9 billion.

Stock stays tied to two dates

For investors, the immediate reference points are Barclays' USD 24.00 target and the October 28 results release. The next report can provide a fresh test of revenue momentum and the assumptions embedded in the target.

The further course of trading is shown by the continuously updated real-time quote of Bausch + Lomb stock.